- Home
- LATA vs LFMD Comparison
LATA vs LFMD Comparison
Compare LATA & LFMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LATA | LFMD |
|---|---|---|
| Founded | 2025 | 1994 |
| Country | United States | United States |
| Employees | N/A | 384 |
| Industry | Blank Checks | Medical/Nursing Services |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 232.5M | 218.1M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | LATA | LFMD |
|---|---|---|
| Price | $10.11 | $4.56 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $9.14 |
| AVG Volume (30 Days) | 65.6K | ★ 998.6K |
| Earning Date | 01-01-0001 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $17.52 |
| Revenue Next Year | N/A | $18.73 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.91 | $2.60 |
| 52 Week High | $10.13 | $12.72 |
Technical Indicators
Market Signals| Indicator | LATA | LFMD |
|---|---|---|
| Relative Strength Index (RSI) | 58.83 | 48.86 |
| Support Level | $9.91 | $3.98 |
| Resistance Level | $10.12 | $5.21 |
| Average True Range (ATR) | 0.00 | 0.32 |
| MACD | -0.00 | -0.00 |
| Stochastic Oscillator | 100.00 | 55.00 |
Price Performance
Historical ComparisonAbout LATA Galata Acquisition Corp. II Class A Ordinary Shares
Galata Acquisition Corp II is a blank check company.
About LFMD LifeMD Inc.
LifeMD Inc is a patient-centric, direct-to-patient healthcare company providing a high-quality, cost-effective, and convenient way for patients to access virtual medical care and pharmacy services. The Company's portfolio of brands within continuing operations is now managed as a single operating segment, Telehealth. Telehealth platform integrates core capabilities, includes: A nationwide pharmacy network, A wholly-owned commercial pharmacy, A fully integrated patient care center, A direct-to-patient marketing infrastructure for acquisition and retention, and AI-enabled clinical and operational technologies.